Lv11
48 积分 2025-12-05 加入
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
52分钟前
已完结
Targeting TROP2 in drug-tolerant persister cells delays EGFR tyrosine kinase inhibitor resistance in non-small-cell lung cancer
1小时前
已完结
Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB–IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial
9个月前
已完结
Cancer organoids 2.0: modelling the complexity of the tumour immune microenvironment
9个月前
已完结
Tertiary lymphoid structures in anticancer immunity
9个月前
已完结
Talquetamab plus daratumumab for the treatment of relapsed or refractory multiple myeloma in the TRIMM-2 study
10个月前
已完结
皖公网安备34019202002308
